Hemoglobin crosfumaril

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Hemoglobin crosfumaril
Accession Number
DB13864
Type
Biotech
Groups
Experimental
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Hemoglobin in which the alpha-subunit are cross-linked intramolecularly.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • DCLHb
  • Hemoglobin A0 (human alpha2 beta2 tetrameric subunit), alpha-chain 99,99'-diamide with (E)-2-butenoic acid
International/Other Brands
HemAssist
Categories
UNII
FXP28WJO7L
CAS number
142261-03-8

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available
ATC Codes
B05AA08 — Hemoglobin crosfumaril

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on June 26, 2017 14:27 / Updated on November 02, 2018 07:47